Researchers recruiting children with autism
Researchers at McGovern Medical School are conducting a 14-week, placebo-controlled research study to assess the safety and effectiveness of an investigational medication (CM-AT) to treat the symptoms of autism in children ages 3 to 8. CM-AT is an enzyme formulation children…
Researchers pinpoint area of brain linked to bipolar disorder
A volume decrease in specific parts of the brain’s hippocampus – long identified as a hub of mood and memory processing – was linked to bipolar disorder in a study led by researchers at McGovern Medical School. The research was…
Psychiatry hosts conference on early identification and intervention for children
“Young Minds: Early Identification and Intervention in Behavioral Health” is the focus of this year’s Psychiatry Update, an annual conference sponsored by the Department of Psychiatry and Behavioral Sciences at McGovern Medical School. The event, scheduled for Saturday, Feb. 4…